iohexol has been researched along with Colitis, Granulomatous in 16 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Excerpt | Relevance | Reference |
---|---|---|
"Crohn disease was depicted by capsule endoscopy in 12 patients (71%), ileoscopy in 11 (65%), CT enterography in nine (53%), and SBFT in four (24%)." | 1.33 | Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy. ( De Petris, G; Fleischer, DE; Hara, AK; Heigh, RI; Hentz, JG; Leighton, JA; Sharma, VK; Silva, AC, 2006) |
"Thirty patients with established Crohn's disease prospectively underwent spiral CT enterography at 45-60 min after distension of the small bowel with 1400 ml of a negative oral contrast material (Mucofalk water enema)." | 1.31 | Multiplanar spiral CT enterography in patients with Crohn's disease using a negative oral contrast material: initial results of a noninvasive imaging approach. ( Doerfler, O; Goritschnig, T; Hinterleitner, T; Petritsch, W; Preidler, KW; Reittner, P; Szolar, DH, 2002) |
"Iohexol is a water-soluble contrast medium that is partly absorbed/permeated through mucosa of the small bowel and excreted unchanged in the urine." | 1.29 | Increased urinary excretion of iohexol after enteral administration in patients with ileal Crohn's disease. A new test for disease activity. ( Edgren, J; Halme, L; Linden, H; von Smitten, K, 1993) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 6 (37.50) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Son, JH | 1 |
Kim, SH | 1 |
Cho, EY | 1 |
Ryu, KH | 1 |
Murphy, KP | 2 |
Crush, L | 1 |
McLaughlin, PD | 2 |
O'Sullivan, HS | 1 |
Twomey, M | 2 |
Lynch, S | 1 |
Bye, J | 1 |
McSweeney, SE | 1 |
O'Connor, OJ | 2 |
Shanahan, F | 1 |
Maher, MM | 2 |
Chan, VE | 1 |
Moloney, F | 1 |
Fung, AJ | 1 |
Chan, FE | 1 |
Kao, T | 1 |
O'Neill, SB | 1 |
Watson, B | 1 |
Lee, SS | 1 |
Kim, AY | 1 |
Yang, SK | 1 |
Chung, JW | 1 |
Kim, SY | 1 |
Park, SH | 1 |
Ha, HK | 1 |
Soyer, P | 1 |
Boudiaf, M | 1 |
Dray, X | 1 |
Sirol, M | 1 |
Martin-Grivaud, S | 1 |
Duchat, F | 1 |
Fargeaudou, Y | 1 |
Hamzi, L | 1 |
Tiah, D | 1 |
Marteau, P | 1 |
Rymer, R | 1 |
Allen, BC | 1 |
Baker, ME | 1 |
Einstein, DM | 1 |
Remer, EM | 1 |
Herts, BR | 1 |
Achkar, JP | 1 |
Davros, WJ | 1 |
Novak, E | 1 |
Obuchowski, NA | 1 |
Chatu, S | 1 |
Pilcher, J | 1 |
Saxena, SK | 1 |
Fry, DH | 1 |
Pollok, RC | 1 |
Fork, FT | 1 |
Karlsson, N | 1 |
Kadhem, S | 1 |
Ohlsson, B | 1 |
Hardie, AD | 1 |
Horst, ND | 1 |
Mayes, N | 1 |
Reittner, P | 1 |
Goritschnig, T | 1 |
Petritsch, W | 1 |
Doerfler, O | 1 |
Preidler, KW | 1 |
Hinterleitner, T | 1 |
Szolar, DH | 1 |
Hara, AK | 1 |
Leighton, JA | 1 |
Heigh, RI | 1 |
Sharma, VK | 1 |
Silva, AC | 1 |
De Petris, G | 1 |
Hentz, JG | 1 |
Fleischer, DE | 1 |
Booya, F | 1 |
Fletcher, JG | 1 |
Huprich, JE | 1 |
Barlow, JM | 1 |
Johnson, CD | 1 |
Fidler, JL | 1 |
Solem, CA | 1 |
Sandborn, WJ | 1 |
Loftus, EV | 1 |
Harmsen, WS | 1 |
Minordi, LM | 1 |
Vecchioli, A | 1 |
Poloni, G | 1 |
Bonomo, L | 1 |
Halme, L | 3 |
Edgren, J | 2 |
von Smitten, K | 2 |
Linden, H | 1 |
Turpeinen, U | 2 |
Stenman, UH | 1 |
Turunen, U | 1 |
Tuominen, J | 1 |
Forsström, T | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Use of Autologous Adult Adipose-Derived Stem/Stromal Cells in Inflammatory Bowel Disease[NCT02952131] | Phase 1/Phase 2 | 100 participants (Anticipated) | Interventional | 2016-11-30 | Enrolling by invitation | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
16 other studies available for iohexol and Colitis, Granulomatous
Article | Year |
---|---|
Comparison of diagnostic performance between 1 millisievert CT enterography and half-standard dose CT enterography for evaluating active inflammation in patients with Crohn's disease.
Topics: Adolescent; Adult; Contrast Media; Crohn Disease; Female; Humans; Image Interpretation, Computer-Ass | 2018 |
The role of pure iterative reconstruction in conventional dose CT enterography.
Topics: Adolescent; Adult; Aged; Contrast Media; Crohn Disease; Female; Gastrointestinal Tract; Humans; Imag | 2015 |
Accurate tissue characterization in low-dose CT imaging with pure iterative reconstruction.
Topics: Adult; Algorithms; Bone Density; Contrast Media; Crohn Disease; Diatrizoate Meglumine; Female; Human | 2017 |
Crohn disease of the small bowel: comparison of CT enterography, MR enterography, and small-bowel follow-through as diagnostic techniques.
Topics: Adolescent; Adult; Contrast Media; Crohn Disease; Female; Gadolinium DTPA; Humans; Image Interpretat | 2009 |
Crohn's disease: multi-detector row CT-enteroclysis appearance of the appendix.
Topics: Adult; Aged; Appendicitis; Case-Control Studies; Chi-Square Distribution; Contrast Media; Crohn Dise | 2010 |
Effect of altering automatic exposure control settings and quality reference mAs on radiation dose, image quality, and diagnostic efficacy in MDCT enterography of active inflammatory Crohn's disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Contrast Media; Crohn Disease; Female; Humans; Iohexol; | 2010 |
Diagnostic accuracy of small intestine ultrasonography using an oral contrast agent in Crohn's disease: comparative study from the UK.
Topics: Administration, Oral; Adult; C-Reactive Protein; Contrast Media; Crohn Disease; Diagnosis, Different | 2012 |
Small bowel enteroclysis with magnetic resonance imaging and computed tomography in patients with failed and uncertain passage of a patency capsule.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Capsule Endoscopy; Capsules; Child; Contrast Media; Croh | 2012 |
Preliminary evaluation of ultra-high pitch computed tomography enterography.
Topics: Adult; Contrast Media; Crohn Disease; Feasibility Studies; Female; Humans; Intestines; Iohexol; Male | 2012 |
Multiplanar spiral CT enterography in patients with Crohn's disease using a negative oral contrast material: initial results of a noninvasive imaging approach.
Topics: Administration, Oral; Adult; Contrast Media; Crohn Disease; Female; Humans; Intestine, Small; Iohexo | 2002 |
Crohn disease of the small bowel: preliminary comparison among CT enterography, capsule endoscopy, small-bowel follow-through, and ileoscopy.
Topics: Adolescent; Adult; Aged; Barium Sulfate; Capsules; Contrast Media; Crohn Disease; Endoscopy, Gastroi | 2006 |
Active Crohn disease: CT findings and interobserver agreement for enteric phase CT enterography.
Topics: Adult; Chi-Square Distribution; Contrast Media; Crohn Disease; Endoscopy, Gastrointestinal; Female; | 2006 |
CT enteroclysis: multidetector technique (MDCT) versus single-detector technique (SDCT) in patients with suspected small-bowel Crohn's disease.
Topics: Adult; Aged; Chi-Square Distribution; Contrast Media; Crohn Disease; Female; Humans; Intestine, Smal | 2007 |
Increased urinary excretion of iohexol after enteral administration in patients with ileal Crohn's disease. A new test for disease activity.
Topics: Administration, Oral; Adult; Crohn Disease; Female; Humans; Ileitis; Iohexol; Male; Middle Aged; Uri | 1993 |
Urinary excretion of iohexol as a marker of disease activity in patients with inflammatory bowel disease.
Topics: Administration, Oral; Adult; Colitis, Ulcerative; Contrast Media; Crohn Disease; Female; Humans; Inf | 1997 |
Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease.
Topics: Adult; Aged; Colitis, Ulcerative; Crohn Disease; Endoscopy, Gastrointestinal; Female; Humans; Inflam | 2000 |